tiprankstipranks
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market
BDRX
Biodexa Pharmaceuticals
RESEARCH TOOLSreports
Want to see BDRX full AI Analyst Report?

Biodexa Pharmaceuticals (BDRX) Income Statement

538 Followers

Biodexa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Biodexa Pharmaceuticals's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Biodexa Pharmaceuticals's net income was £-2.56M. See Biodexa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 0.00£ 0.00£ 381.00K£ 699.00K£ 578.00K
Gross Profit
£ -184.86K£ -5.44M£ -3.69M£ -4.41M£ -4.08M
Operating Expenses
£ 8.08M£ 3.76M£ 4.33M£ 4.52M£ 2.92M
Depreciation and Amortization
£ 184.86K£ 117.00K£ 283.00K£ 174.00K£ 403.00K
EBITDA
£ -8.08M£ -9.08M£ -7.16M£ -8.26M£ -5.66M
Operating Income
£ -8.27M£ -9.20M£ -8.01M£ -8.93M£ -7.00M
Other Income/Expenses
£ 1.92M£ 3.22M£ 529.00K£ 444.00K£ 892.00K
Pretax Income
£ -6.35M£ -5.98M£ -7.49M£ -8.49M£ -6.11M
Net Income
£ -6.24M£ -5.73M£ -7.08M£ -7.66M£ -5.46M
Per Share Metrics
Basic EPS
£ -60.00£ -1.16M£ -229.00K£ -4.94M£ -3.52M
Diluted EPS
£ -60.00£ -1.16M£ -229.00K£ -4.94M£ -3.52M
Weighted Average Shares Outstanding
 54.86K 61.95K 30.00 1.00 1.00
Weighted Average Shares Outstanding (Diluted)
 54.86K 61.95K 30.00 1.00 1.00
Currency in GBP

Biodexa Pharmaceuticals Earnings and Revenue History